Mar 19,2020

Addiction focused startup Quit Genius scores $11M in Series A funding

Yesterday morning addiction focused digital therapeutic Quit Genius scored $11 million in Series A funding. Octopus Ventures led the round with participation from Y Combinator, Startup Health and Triple Point Ventures. This brings the company's total funding pot to $13.5 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 08,2020

SilverCloud Health Announces $16M Series B Funding for Digital Mental Health Platform

SilverCloud Health, the world's leading digital mental health platform for healthcare systems and providers, health plans, and employers, today announced a $16 million Series B funding round led by MemorialCare Innovation Fund, which included LRVHealth, OSF Ventures and UnityPoint Health Ventures, elevating the company’s total funding to more than $30 million. Existing investors Act Venture Capital and B Capital Group participated in the round as well.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 09,2020

Berlin-based Digital Health Start-up HelloBetter raises millions in seed funding round

Get.On Institut GmbH, which operates under the brand name HelloBetter since the beginning of the year, today announced the closing of a financing round in the single-digit million range. Together with funds raised by its research team, the start-up now has almost five million euros at its disposal to finance further growth. Already in late summer 2019, the first money was made available through a convertible loan, enabling the team to expand from five to around 40 employees. The lead investor of the round is an holding company based in Hamburg. Other investors in the round include the Ideamed Gesundheitsgruppe from Munich (a psychotherapeutic hospital operator), and a consortium of business angels from the health and insurance sectors.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Apr 13,2020

Wellthy Therapeutics has raised $4 million in pre-Series A funding

Wellthy Therapeutics, a digital-therapeutics company targeting chronic-disease prevention, management and reversal, has raised $4 million in pre-Series A funding from Saama Capital, which has purchased a roughly 16% stake in the Southeast Asia company with its investment. In addition to expanding into new regions, the company said that it will be using these funds to prepare for the launch of its digital respiratory therapeutic portfolio.

FUNDING PRE-SERIES A
View Analyst & Ambassador Comments
Go to original news
May 06,2020

Palo Alto company Limbix grabs $9M to develop a digital therapeutic for teens with depression

Digital mental health company Limbix scored $9 million in Series A funding. The new round was led by GSR Ventures with participation from sequoia Capital, Storm Ventures, NexGen Venture Partners and BIXINK Therapeutics. This comes roughly four months after the Palo Alto-based startup was selected as one of 27 digital health companies in MassChallenge HealthTech’s 2020 accelerator class.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 18,2020

Sleep, stress app maker Big Health locks in $39M Series B raise

Big Health, maker of digital health apps targeting poor sleep, worry and anxiety, has announced a $39 million Series B raise. Gilde Health and Morningside Ventures headlined the funding. Samsung NEXT also participated in the raise, as did prior backers Kaiser Permanente Ventures and Octopus Ventures. The digital behavioral health company said that the raise will support new product development, as well as growth of its distribution channels and commercialization efforts.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 19,2020

Kaia Health Lands $26M to Expand AI-Driven Digital Therapeutics for MSK Conditions & COPD

Kaia Health, a digital therapeutics company focused on helping people manage chronic conditions, today announced that it closed a $26 million Series B funding round, bringing its total funds raised to date to $50 million. The round was led by Optum Ventures, Idinvest, and capital300 with participation from existing investors Balderton Capital and Heartcore Capital, as well as Symphony Ventures (an investment partnership with world #1 golfer Rory McIlroy). Kaia Health will use the proceeds to drive the growth of its core digital therapy solutions for people managing musculoskeletal (MSK) conditions, and fund expansion into new conditions such as COPD, where its digitally delivered multi-modal therapy is also clinically effective.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 07,2020

Pear Therapeutics Announces $50 Million Credit Facility from Perceptive Advisors

Pear Therapeutics today announced that it closed a credit facility for up to $50 million from Perceptive Advisors, a leading life sciences investment firm. In connection with the financing, Pear issued warrants to Perceptive, and Sam Chawla of Perceptive received board observer rights. Pear intends to use the proceeds for working capital, repayment of existing debt, and general corporate purposes, including commercialization activities for the Company’s three FDA-authorized prescription digital therapeutics (PDTs).

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Jul 31,2020

DarioHealth Announces $28.6 Million Private Placement

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel. The company received aggregate gross proceeds of approximately $28.6 million, before deducting placement agent fees and other offering expenses. The company's largest existing shareholder, Nantahala Capital Management, LLC (on behalf of client funds and accounts), was joined by new investors including funds managed by Manchester Management Company LLC, Soleus Capital Management L.P. as well as leading Israeli institutional investors such as Phoenix insurance, Mor provident fund, Psagot investment house.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Aug 24,2020

One Drop Announces Nearly $35 million Series C Financing Led By Bayer

One Drop, a leader in digital solutions for people living with diabetes and other chronic conditions, today announced that it has closed on a $34.7 million Series C financing led by Bayer.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING